RECRUITING

3D DL Ozteo in the Detection of Osseous Changes in Patients with Inflammatory Arthritis

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This project intends to explore and validate the utility of new MRI pulse sequence, 3D DL oZTEo, in the detection of osseous erosions of the hand in patients with inflammatory arthritis. The detection of osseous structural changes, such as erosive disease, is routinely assessed in patients with rheumatic conditions such as rheumatoid arthritis, as it alters clinical management, and in some cases assists in diagnosis. Currently, this is most often assessed with radiography and conventional MRI.

Official Title

Evaluation of 3D DL OZTEo in the Detection of Osseous Changes in Patients with Inflammatory Arthritis

Quick Facts

Study Start:2024-12-05
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06383585

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult patients ≥18 years of age
  2. * Hand radiographs performed within the past 3-6 months with imaging results available for analysis
  3. * Hand radiographs confirm the presence of bony erosions
  4. * Scheduled for a hand MRI as part of their routine clinical care at Mayo Clinic Rochester
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Naveen S Murthy, MD
CONTACT
507-284-8548
Murthy.Naveen@mayo.edu

Principal Investigator

Naveen Murthy, MD
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic in Rochester
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Naveen Murthy, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-05
Study Completion Date2026-12

Study Record Updates

Study Start Date2024-12-05
Study Completion Date2026-12

Terms related to this study

Additional Relevant MeSH Terms

  • Inflammatory Arthritis